Concepedia

Zhiwei Wang

ZW

8

Publications

352

Citations

8

H-Index

2006

Active since

Affiliations

BeiGene (China)(Current)

Zhiwei Wang is an author at BeiGene (China) specializing in medicine, pharmacology, and tumor biology.

ORCID

Top concepts

Publications per year

2006–2024

8

Publications

8

Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors

Zhiwei Wang, Baogen Wu, Kelli Kuhen et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 69 citations

, , +9

Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development

Hexiang Wang, Bo Ren, Ye Liu et al. · Journal of Medicinal Chemistry · 2020 · 69 citations · Full text

Sonrotoclax overcomes BCL2 G101V mutation–induced venetoclax resistance in preclinical models of hematologic malignancy

Jiuyang Liu, Shuran Li, Qin Wang et al. · Blood · 2024 · 61 citations · Full text

Interaction mechanism of ferritin protein with chlorogenic acid and iron ion: The structure, iron redox, and polymerization evaluation

Rui Yang, Jing Tian, Yuqian Liu et al. · Food Chemistry · 2021 · 54 citations

, , +9

Abstract 2597: BGB-3111 is a novel and highly selective Bruton's tyrosine kinase (BTK) inhibitor

Na Li, Zhijian Sun, Ye Liu et al. · Cancer Research · 2015 · 47 citations

, , +21

Rows per page

1–5 of 8